Woodline Partners LP Roivant Sciences Ltd. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

A detailed history of Woodline Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Woodline Partners LP holds 8,686,476 shares of ROIV stock, worth $108 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
8,686,476
Previous 8,000,939 8.57%
Holding current value
$108 Million
Previous $84.6 Million 18.53%
% of portfolio
0.91%
Previous 0.85%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$10.17 - $12.5 $6.97 Million - $8.57 Million
685,537 Added 8.57%
8,686,476 $100 Million
Q2 2024

Aug 14, 2024
SELL
$10.36 - $11.74 $32.9 Million - $37.2 Million
-3,171,367 Reduced 28.39%
8,000,939 $84.6 Million
Q1 2024

May 15, 2024
BUY
$9.87 - $11.8 $49.6 Million - $59.2 Million
5,020,539 Added 81.61%
11,172,306 $118 Million
Q4 2023

Feb 14, 2024
SELL
$8.38 - $11.58 $8.57 Million - $11.8 Million
-1,022,486 Reduced 14.25%
6,151,767 $69.1 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $33 Million - $44.5 Million
3,377,382 Added 88.95%
7,174,253 $83.8 Million
Q2 2023

Aug 14, 2023
BUY
$7.09 - $10.08 $1.68 Million - $2.38 Million
236,320 Added 6.64%
3,796,871 $38.3 Million
Q1 2023

May 15, 2023
SELL
$6.92 - $9.98 $7.93 Million - $11.4 Million
-1,145,434 Reduced 24.34%
3,560,551 $26.3 Million
Q4 2022

Feb 14, 2023
BUY
$3.36 - $7.99 $7.41 Million - $17.6 Million
2,206,650 Added 88.29%
4,705,985 $37.6 Million
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $1.27 Million - $12.1 Million
2,499,335 New
2,499,335 $8.05 Million

Others Institutions Holding ROIV

# of Institutions
311
Shares Held
508M
Call Options Held
1.26M
Put Options Held
2.52M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.79B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email